Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Short term Debt (2009 - 2026)

Updated

Analysis

Vertex Pharmaceuticals (VRTX) Short term Debt (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 999.60 Mn
Dec 31, 2016 300.00 Mn
Sep 30, 2016 297.75 Mn
Jun 30, 2016 221.58 Mn
Mar 31, 2016 146.25 Mn
Dec 31, 2015 71.30 Mn
Jun 30, 2015 42.87 Mn
Mar 31, 2015 28.53 Mn
Dec 31, 2014 14.21 Mn
Dec 31, 2009 32.07 Mn
API Access

Vertex Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY